DK155173B - Fremgangsmaade til fremstilling af praeparater af n-(2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsyre med forsinket frigoerelse - Google Patents

Fremgangsmaade til fremstilling af praeparater af n-(2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsyre med forsinket frigoerelse Download PDF

Info

Publication number
DK155173B
DK155173B DK455274AA DK455274A DK155173B DK 155173 B DK155173 B DK 155173B DK 455274A A DK455274A A DK 455274AA DK 455274 A DK455274 A DK 455274A DK 155173 B DK155173 B DK 155173B
Authority
DK
Denmark
Prior art keywords
furosemide
release
furfuryl
sulfamoyl
preparation
Prior art date
Application number
DK455274AA
Other languages
Danish (da)
English (en)
Other versions
DK455274A (nl
Inventor
Gebhard Dahlhausen
Hans-Werner Dibbern
Werner Fuelberth
Gerhard Ross
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5890849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK155173(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK455274A publication Critical patent/DK455274A/da
Publication of DK155173B publication Critical patent/DK155173B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK455274AA 1973-08-28 1974-08-27 Fremgangsmaade til fremstilling af praeparater af n-(2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsyre med forsinket frigoerelse DK155173B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2343218A DE2343218C2 (de) 1973-08-28 1973-08-28 Furosemid enthaltende Pellets
DE2343218 1973-08-28

Publications (2)

Publication Number Publication Date
DK455274A DK455274A (nl) 1975-04-28
DK155173B true DK155173B (da) 1989-02-27

Family

ID=5890849

Family Applications (1)

Application Number Title Priority Date Filing Date
DK455274AA DK155173B (da) 1973-08-28 1974-08-27 Fremgangsmaade til fremstilling af praeparater af n-(2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsyre med forsinket frigoerelse

Country Status (17)

Country Link
US (1) US4324779A (nl)
JP (1) JPS563849B2 (nl)
AT (1) AT344914B (nl)
BE (1) BE819294A (nl)
CA (1) CA1063024A (nl)
DE (1) DE2343218C2 (nl)
DK (1) DK155173B (nl)
EG (1) EG14662A (nl)
FI (1) FI249774A (nl)
FR (1) FR2242076B1 (nl)
GB (1) GB1478715A (nl)
HU (1) HU171769B (nl)
IL (1) IL45521A (nl)
MX (1) MX3585E (nl)
NL (1) NL7411269A (nl)
SE (1) SE7410788L (nl)
ZA (1) ZA745443B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1086226A (en) * 1976-11-26 1980-09-23 Yegnaswami Raghunathan Ion exchange resin prolonged release pharmaceutical preparations
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
JPH01130957U (nl) * 1988-02-29 1989-09-06
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
US3456049A (en) * 1965-05-25 1969-07-15 Ciba Geigy Corp Gradual-release tablet
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung

Also Published As

Publication number Publication date
FR2242076A1 (nl) 1975-03-28
CA1063024A (en) 1979-09-25
MX3585E (es) 1981-03-20
DE2343218C2 (de) 1986-08-07
AT344914B (de) 1978-08-25
GB1478715A (en) 1977-07-06
IL45521A (en) 1978-07-31
NL7411269A (nl) 1975-03-04
DE2343218A1 (de) 1975-04-03
FR2242076B1 (nl) 1978-07-28
JPS563849B2 (nl) 1981-01-27
IL45521A0 (en) 1974-11-29
DK455274A (nl) 1975-04-28
ZA745443B (en) 1975-08-27
HU171769B (hu) 1978-03-28
FI249774A (nl) 1975-03-01
SE7410788L (nl) 1975-03-03
ATA694274A (de) 1977-12-15
EG14662A (en) 1984-09-30
AU7272874A (en) 1976-03-04
BE819294A (fr) 1975-02-28
JPS5076217A (nl) 1975-06-21
US4324779A (en) 1982-04-13

Similar Documents

Publication Publication Date Title
JP3194974B2 (ja) 標的制御釈放薬剤
DK174949B1 (da) Formuleringer med forlænget frigivelse og deres fremstilling
US4752470A (en) Controlled release indomethacin
FI78835B (fi) Foerfarande foer framstaellning av en ny dipyridamol-retardform.
DK155173B (da) Fremgangsmaade til fremstilling af praeparater af n-(2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsyre med forsinket frigoerelse
RU2240110C2 (ru) Новый препарат
EP0339506B1 (de) Orales osmotisches System mit verbesserter Haftwirkung der Membran am Kern
KR100187950B1 (ko) 미노시클린의 1일-1회 투여 제약학적 조달계 및 그의 제조방법
TWI232755B (en) Oral medicament, and a supporting substrate complex of oral medicament
PL188834B1 (pl) Farmaceutyczne formulacje zawierające tramadol lub jego fizjologicznie akceptowane sole oraz sposóbwytwarzania tych formulacji
JPH0643312B2 (ja) 薬学的調合剤
EP0616802B1 (en) Oral preparation for release in lower digestive tracts
FI86373C (fi) Belaeggning foer en farmaceutiskt tablett med foerdroejd effekt och foerfarande foer framstaellning av en tablett.
EP0339420B1 (de) DHP-Retard-Zubereitung
NO166063B (no) Baerebelegg til belegging av et medikament for oppnaaelse av et farmasoeytisk preparat med forlenget frigivelse.
JP2599189B2 (ja) 味覚遮蔽剤を含有している咀嚼可能な薬物錠剤
DK164843B (da) Theophyllin-retardpraeparat og fremgangsmaade til fremstilling heraf
DE2328580A1 (de) Arzneimittelformulierung mit kontrollierter verweilzeit im gastrischen bereich
CN101984974A (zh) 一种用于治疗2型糖尿病的药物组合物的制备方法
RU2411035C2 (ru) Лекарственная форма с модифицированным высвобождением 6-метил-2-этил-3-гидроксипиридина сукцината
US20060165808A1 (en) Microcapsules for the delayed, controlled release of perindopril
JP3282832B2 (ja) 持続性錠剤
US3126320A (en) Enteric-coated tablets of dextran sul-
JP3122478B2 (ja) 下部消化管放出型経口製剤
CN107913259A (zh) 一种盐酸二甲双胍控释片及其制备方法

Legal Events

Date Code Title Description
PRF Application refused